Showing results (91-100 of 175) with videos related to
Sort By:
Pageof 18
Epilepsia|April 16, 2015
Epilepsy and deprivation, a data linkage studyWilliam O Pickrell, Arron S Lacey, Owen G Bodger, et al.European Journal of Neurology|February 9, 2026
MOGAD in South Wales: Diagnostic Evolution and Disease EpidemiologySophie Voase, Patrick Waters, Stephen Jolles, et al.The Lancet. Neurology|April 6, 2015
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparatorJacqueline Palace, Martin Duddy, Thomas Bregenzer, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 17, 2012
Long-term outcome of paediatric-onset multiple sclerosis: a population-based studyKatharine E Harding, Kate Liang, Mark D Cossburn, et al.Brain : a Journal of Neurology|September 14, 2013
Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delayRhys H Thomas, Seo-Kyung Chung, Sian E Wood, et al.Annals of Neurology|October 19, 2022
Fewer COVID-19 Neurological Complications with Dexamethasone and RemdesivirAlexander Grundmann, Chieh-Hsi Wu, Marc Hardwick, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 6, 2016
Cluster of atypical adult Guillain-Barré syndrome temporally associated with neurological illness due to EV-D68 in children, South Wales, United Kingdom, October 2015 to January 2016Christopher J Williams, Rhys H Thomas, Trevor P Pickersgill, et al.Journal of the Neurological Sciences|August 12, 2020
Serum neurofilament-light concentration and real-world outcome in MSValerie Anderson, Emily Bentley, Sam Loveless, et al.Brain Pathology (Zurich, Switzerland)|July 15, 2017
Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosisSam Loveless, James W Neal, Owain W Howell, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 5, 2018
How common is truly benign MS in a UK population?Emma Clare Tallantyre, Paula C Major, Michael J Atherton, et al.Pageof 18